ArticleScientific reports2019

Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients.

Marco Iannetta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.